The Need For Independent Insight And The Role Of Data Monitoring And Endpoint Adjudication Committees
Data Monitoring Committees (DMCs) and Endpoint Adjudication Committees (EACs) provide crucial validation on clinical data as additional support for regulatory submissions and commercial strategy. Partnering with outside experts can lead to better-defined data gathering, earlier risk signal detection and, ultimately, a value-enhanced, streamlined approach to leveraging the intelligence gathered from clinical trials.
Without the insights that these committees provide, sponsors risk missed signals, conflicts of interest and delays, and squandered resources. Trials that should proceed may quickly drag, and trials that should be halted continue for too long. The financial and human cost can be massive.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.